Establishment Labs Holdings Inc.

Moat Score
Safety Score

Market Cap $922.86M
PE -11
Debt $219.58M
Cash $90.35M
EV $1.05B
FCF -$64.63M

Earnings

loading chart...

Sales & Net Margins

loading chart...

Earnings	-$84.60M
EBIT	-$49.99M
ROE	-159%
ROA	-14%
FCF	-$64.63M
Equity	$53.10M
Growth Stability	1
PE	-10.91
PB	17.38
P/FCF	-14.28
P/S	5.56
Price/Cash	0.1
Debt/Equity	4.14
Debt/FCF	-3.4
Net Margins	-51%
Gross Margins	66%
Op. Margins	-30%
Sales Growth YoY	41%
Sales Growth QoQ	11%
Sales CAGR	20%
Equity CAGR	-3%
Earnings Growth YoY	68%

Earnings Growth QoQ	107%
Sales CAGR 5Y	18%
Equity CAGR 5Y	-15%
Earnings CAGR 3Y	4%
Sales CAGR 3Y	4%
Equity CAGR 3Y	61%
Market Cap	$922.86M
Revenue	$166.03M
Assets	$346.83M
Total Debt	$219.58M
Cash	$90.35M
Shares Outstanding	28.16M
EV	1.05B
Moat Score	2%
Safety Score	54%
Working Capital	174.76M
Current Ratio	3.56
Gross Profit	$109.53M
Shares Growth 3y	7%
Equity Growth QoQ	62%
Equity Growth YoY	189%

Assets & ROA

loading chart...

Stockholders Equity & ROE

loading chart...

Establishment Labs Holdings Inc is a medical technology company engaged in offering medical devices and aesthetic products. It is involved in designing, manufacturing, and marketing silicone-filled breast and body shaping implants. The company markets its products under Motiva implants Brand. It distributes its products to medical distributors; and physicians, hospitals, and clinics in the form of direct sales. Its geographical segments are Europe, Latin America, Asia-Pacific/Middle East, and Others.

SEC Filings

Direct access to Establishment Labs Holdings Inc. (ESTA) Annual Reports (10K) and Quarterly Reports (10Q) from the SEC website.

2024
- 10-K Dec 31
- 10-Q Sep 30
- 10-Q Jun 30
- 10-Q Mar 31
2023
- 10-K Dec 31
- 10-Q Sep 30
- 10-Q Jun 30
- 10-Q Mar 31
2022
- 10-K Dec 31
- 10-Q Sep 30
- 10-Q Jun 30
- 10-Q Mar 31

Sector Comparison

How does Establishment Labs Holdings Inc. compare to its competitors?

Not enough data to generate a comparison chart between Establishment Labs Holdings Inc. and its competitors. Please check back later.

Peter Lynch's Chart

This chart shows the current pricing of Establishment Labs Holdings Inc. compared to its past. The addition of the earnings trend line provides further insights into the company's earnings power.

loading chart...

Establishment Labs Holdings Inc. Discounted Cash Flow

Fully customizable DCF calculator online for Establishment Labs Holdings Inc..

Years

Calculation mode

= -$646M

	0	1	2	3	4	5	6	7	8	9	10	TV
fcf	-$65M	-$65M	-$65M	-$65M	-$65M	-$65M	-$65M	-$65M	-$65M	-$65M	-$65M	-$646M
DCF		-$59M	-$53M	-$49M	-$44M	-$40M	-$36M	-$33M	-$30M	-$27M	-$25M	-$249M
Value	-$646M

Competitiveness and MOAT

High margins render the company resilient under dire circumstances, hence able to drive competitors out or acquire them. ROE and ROA measure the average flow generated by each invested dollar. Their marginal value is a forecast of future growth, and it is considered by Buffett and Munger the most important single indicator.

Years	12/2017	12/2018	12/2019	12/2020	12/2021	12/2022	12/2023	12/2024	TTM
Net Margins	-101%	-34%	-43%	-45%	-32%	-47%	-48%	-51%	-51%
ROA	-	-18%	-27%	-18%	-18%	-19%	-24%	-14%	-14%
ROE	-	-30%	-96%	-51%	-81%	919%	-427%	-159%	-159%

Bad Net Margins (-50.95%)

Net Margins are too low to guarantee profitability in case of higher costs or higher interest rates. Furthermore lower margins cause higher earnings’ volatility.

Safety and Stability

Being debt the number one cause of investment losses and company death, the ratio Debt/FCF is of utmost importance to guarantee safety. On the other hand the Graham’s stability measures the drawdown of earnings, hence indicating the reliability of the flow generated by the company.

Years	12/2017	12/2018	12/2019	12/2020	12/2021	12/2022	12/2023	12/2024	TTM
Debt over FCF	-	-	-1.33	-3.34	-1.71	-2.14	-1.82	-3.4	-3.4
Debt over Equity	-	-	1.22	0.66	1.02	-21.44	10.26	4.14	4.14
Growth Stability	-	-	-	-	-	-	-	-	1

Good Debt/FCF ratio (-3.4)

Net Margins are high enough to offer a good protection on the profits in case of higher costs or higher interests. Furthermore higher margins reduce earnings’ volatility.

Bad Debt/Equity ratio (4.14)

The company is overleveraged and has a bad balance between equity and debt.

Good Graham’s Stability (1)

The company has a good stability in its earnings, which is a sign of a good competitive advantage.

Growth

Growth can be dangerous when forecasting, simply projecting the current growth is in general wrong. A company passes through multiple phases, from being young and unprofitable, to the first periods of profitability and high growth, until it arrives at a period of regime with limited growth. Identifying in which phase the company is in may help forecasting.

Years	12/2017	12/2018	12/2019	12/2020	12/2021	12/2022	12/2023	12/2024	CAGR 5Y
Revenue YoY growth	-	76%	46%	-5%	50%	28%	2%	1%	18%
Earnings YoY growth	-	-40%	81%	-0%	8%	83%	4%	8%	-
Equity YoY growth	-	-1K%	-43%	89%	-32%	-116%	-325%	189%	-15%
FCF YoY growth	-	8%	2%	-59%	104%	170%	26%	-38%	-